Performance of a next-generation rapid lipoarabinomannan urine assay for tuberculosis in outpatients with and without HIV in South Africa and Uganda: a two-centre diagnostic accuracy study
The Lancet Microbe · 2026-10 · 7 (10) · 101418
DOI: 10.1016/j.lanmic.2026.101418 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift The Lancet Microbe, 2026-10. Verfasst von Beston Hamasur und 13 weiteren Autor:innen. Beteiligte Einrichtung: Biopromic, Solna, Sweden; Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Solna, Sweden. Hauptthemen laut MEDLINE: Lipopolysaccharides, HIV Infections, Tuberculosis, Pulmonary, Tuberculosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European and Developing Countries Clinical Trials Partnership, Foundation for the National Institutes of Health, Science for Africa Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Biopromic, Solna, Sweden; Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Solna, Sweden.
- DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research; South African Medical Research Council Centre for Tuberculosis Research; Division of Molecular Biology and Human Genetics, Faculty of Medicine and Healt…
- Department of Medical Microbiology, Makerere University, Kampala, Uganda.
- Biopromic, Solna, Sweden.
- Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.
- Department of Immunology and Molecular Biology, Makerere University College of Health Sciences, Kampala, Uganda.
Förderung
- European and Developing Countries Clinical Trials Partnership
- Foundation for the National Institutes of Health
- Science for Africa Foundation
- National Department of Health
- National Treasury
- Universiteit Stellenbosch
- Foreign, Commonwealth and Development Office
- Wellcome Trust
Zitieren
APA
Hamasur, B., Okunola, A. O., Sserubiri, J., Nwamba, W. V., Abdulgader, S. M., Ignatowicz, L., Rasool, O., Nabatanzi, R., Lorente, S. P., Giraldos, D., Joloba, M., Warren, R. M., Ssengooba, W., & Theron, G. (2026). Performance of a next-generation rapid lipoarabinomannan urine assay for tuberculosis in outpatients with and without HIV in South Africa and Uganda: a two-centre diagnostic accuracy study. The Lancet Microbe, 7(10), 101418. https://doi.org/10.1016/j.lanmic.2026.101418
Vancouver
Hamasur B, Okunola AO, Sserubiri J, Nwamba WV, Abdulgader SM, Ignatowicz L, et al. Performance of a next-generation rapid lipoarabinomannan urine assay for tuberculosis in outpatients with and without HIV in South Africa and Uganda: a two-centre diagnostic accuracy study. The Lancet Microbe. 2026;7(10):101418. doi:10.1016/j.lanmic.2026.101418
BibTeX
@article{Hamasur2026,
author = {Hamasur, Beston and Okunola, Anna O and Sserubiri, James and Nwamba, Welile V and Abdulgader, Shima M and Ignatowicz, Lech and Rasool, Omid and Nabatanzi, Rose and Lorente, Sara Puertas and Giraldos, David and Joloba, Moses and Warren, Robin M and Ssengooba, Willy and Theron, Grant},
title = {Performance of a next-generation rapid lipoarabinomannan urine assay for tuberculosis in outpatients with and without HIV in South Africa and Uganda: a two-centre diagnostic accuracy study},
journal = {The Lancet Microbe},
year = {2026},
volume = {7},
number = {10},
pages = {101418},
doi = {10.1016/j.lanmic.2026.101418}
}
EUVIMED